← Leaderboards
Maria Lauda Tomasi
University Of Southern California
$4,477,361
Attributed
$4,477,361
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $890.5K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,477,361 · 5
By mechanism
R01$3,074,344 · 2
K01$802,993 · 1
R21$446,250 · 1
F32$153,774 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Andrew Abba Stolz$9,063,253
- Michael M.c. Lai$6,621,554
- Karen L Lindsay$3,850,131
- Lily Dara$2,281,417
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsPreventPathway InteractionsPlayEthanolCellsGenesAlcoholic Liver DiseasesSignal TransductionModificationLiverCirrhosisPost-Translational Protein ProcessingUbiquitin-Conjugating EnzymesHepatocyteAlcohol AbuseSiteDna RepairBiologicalAlcoholsIn VivoEnzymesHepaticNuclear
Grant awards (17)
Role of StAR-related lipid transfer protein 10 in alcohol-induced breast cancer progression$433,714
R01 · FY2025 · AA · contact PI
Role of phospho UBC9 in alcohol-associated liver disease$425,179
R01 · FY2025 · AA · contact PI
Role of StAR-related lipid transfer protein 10 in alcohol-induced breast cancer progression$441,680
R01 · FY2024 · AA · contact PI
Role of phospho UBC9 in alcohol-associated liver disease$433,445
R01 · FY2024 · AA · contact PI
Role of StAR-related lipid transfer protein 10 in alcohol-induced breast cancer progression$449,496
R01 · FY2023 · AA · contact PI
Role of phospho UBC9 in alcohol-associated liver disease$440,960
R01 · FY2023 · AA · contact PI
Role of phospho UBC9 in alcohol-associated liver disease$449,870
R01 · FY2022 · AA · contact PI
A novel biological crosstalk between sumoylation and mitochondria dysfuntion in alcoholic liver disease$201,875
R21 · FY2020 · AA · contact PI
A novel biological crosstalk between sumoylation and mitochondria dysfuntion in alcoholic liver disease$244,375
R21 · FY2019 · AA · contact PI
Role of Sumoylation in Alcoholic Liver Disease$161,568
K01 · FY2017 · AA · contact PI
Role of Sumoylation in Alcoholic Liver Disease$161,568
K01 · FY2016 · AA · contact PI
Role of Sumoylation in Alcoholic Liver Disease$161,568
K01 · FY2015 · AA · contact PI
Role of Sumoylation in Alcoholic Liver Disease$156,721
K01 · FY2014 · AA · contact PI
Role of sumoylation in alcoholic liver disease$161,568
K01 · FY2013 · AA · contact PI
Role of SAMe on UBC9 and sumolyation in liver cancer and alcoholic liver injury$54,242
F32 · FY2012 · AA · contact PI
Role of SAMe on UBC9 and sumolyation in liver cancer and alcoholic liver injury$51,626
F32 · FY2011 · AA · contact PI
ROLE OF S-ADENOSYLMETHIONINE ON UBC9 AND SUMOYLATION IN LIVER CANCER AND ALCOHOLI$47,906
F32 · FY2010 · AA · contact PI